Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shengtai Pharma to Seek Growth in International Sales

publication date: Oct 30, 2008

Shengtai Pharmaceutical will begin a push to sell its pharmaceutical grade glucose products internationally. To get this done, the company has restructured its international sales team. The company said it already has customers in 70 countries, but according to SEC documents, Shengtai realized just 17% of its pharmaceutical product revenues from foreign countries in fiscal 2008 (ended June 30). Shengtai has added its capacity to produce pharmaceutical grade glucose, raising its annual product capability by 120,000 tons to approximately 180,000 tons. More details...

Stock Symbol: (OTCBB: SGTI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here